Sentences with phrase «net cash per share»

He owns Cisco, which he calls a world - class player with a «shockingly» low valuation considering it has $ 5.50 of net cash per share on its balance sheet.

And obviously anything like those kind of returns easily supports the annual $ 0.67 dividend (for a 6.6 % dividend yield), and TFG also has $ 3.90 net cash per share anyway.

Should you be focused on the NCAV of 42828 million KRW (69,996.00 Million KRW Current Assets — 27,168.00 Million KRW Total Liabilities)-- which comes to $ 1.42 Net Cash per share?

However on the results front, the company continues to wind down, and with about $.45 net cash per share and generating about $.13 per quarter (at least for the next few quarters... after that??)

Valuation — with regards to valuation of the company at $ 240 per share, this includes valuing the business at $ 216 per share (at 18x our FY 2016 earnings estimate of $ 12 per share) plus net cash per share of $ 24 ($ 150 billion of net cash less the tax effect on international cash for repatriation, which we estimate to ultimately be 6 %, and for simplicity purposes, apply to all cash on balance sheet rather than just the international cash).

Not exact matches

The following tables provide reconciliations of adjusted cash flows from operations, adjusted net income (loss) and adjusted EBITDAX to their most comparable U.S. GAAP measures (in millions, except per share data):

These non-GAAP measures include non-GAAP gross margin, non-GAAP operating income, non-GAAP non-operating income, net, non-GAAP net income, non-GAAP diluted (loss) earnings per share and free cash flow.

Icahn said Apple's price - to - earnings ratio should be about 20 times, which taken together with net cash of $ 22 per share works out to $ 216 per share.

HPE will pay $ 12.50 per share in cash, representing a net cash purchase price at closing of $ 1.0 billion.

Echelon is now focusing its growth on «smart» commercial & municipal LED lighting (although its fab-less chip business has apparently now stabilized after a long decline), and if the lighting business accelerates (and it could, due to recent sales force hires and new products), I think there's a chance it can hit a break - even annualized revenue run - rate of $ 40 million by Q4 - 2019 (pushed back from my earlier hoped - for timeline) at which point — assuming $ 14 million of remaining net cash (vs. an estimated $ 18 million at the end of Q2 2018) and 4.7 million shares outstanding (vs 4.52 million today), an enterprise value of 1x revenue on this 53 % gross margin company would put the stock in the mid - $ 11s per share.

The performance goals upon which the payment or vesting of any Incentive Award (other than Options and stock appreciation rights) that is intended to qualify as Performance - Based Compensation depends shall relate to one or more of the following Performance Measures: market price of Capital Stock, earnings per share of Capital Stock, income, net income or profit (before or after taxes), economic profit, operating income, operating margin, profit margin, gross margins, return on equity or stockholder equity, total shareholder return, market capitalization, enterprise value, cash flow (including but not limited to operating cash flow and free cash flow), cash position, return on assets or net assets, return on capital, return on invested

Under the Bonus Plan, our compensation committee, in its sole discretion, determines the performance goals applicable to awards, which goals may include, without limitation: attainment of research and development milestones, sales bookings, business divestitures and acquisitions, cash flow, cash position, earnings (which may include any calculation of earnings, including but not limited to earnings before interest and taxes, earnings before taxes, earnings before interest, taxes, depreciation and amortization and net earnings), earnings per share, net income, net profit, net sales, operating cash flow, operating expenses, operating income, operating margin, overhead or other expense reduction, product defect measures, product release timelines, productivity, profit, return on assets, return on capital, return on equity, return on investment, return on sales, revenue, revenue growth, sales results, sales growth, stock price, time to market, total stockholder return, working capital, and individual objectives such as MBOs, peer reviews, or other subjective or objective criteria.

Examples of forward - looking statements include, but are not limited to, statements we make regarding the Company's plans, assumptions, expectations, beliefs and objectives with respect to store openings and closings; product introductions; sales; sales growth; sales trends; store traffic; retail prices; gross margin; operating margin; expenses; interest and other expenses, net; effective income tax rate; net earnings and net earnings per share; share count; inventories; capital expenditures; cash flow; liquidity; currency translation; growth opportunities; litigation outcomes and recovery related thereto; the collectability of amounts due under financing arrangements with diamond mining and exploration companies; and certain ongoing or planned product, marketing, retail, manufacturing, information systems development, upgrades and replacement, and other operational and strategic initiatives.

ATLANTA & MINNEAPOLIS --(BUSINESS WIRE)-- Nov. 28, 2017 — Arby's Restaurant Group, Inc. («ARG») and Buffalo Wild Wings, Inc. (Nasdaq: BWLD)(«BWW») today announced that the companies have entered into a definitive merger agreement under which ARG will acquire BWLD for $ 157 per share in cash, in a transaction valued at approximately $ 2.9 billion, including BWW's net debt.

For instance, 3M increased its dividend by 16 % in fiscal 2017, backed by 12.4 % growth in adjusted earnings per share and free cash flow generation of nearly $ 4.9 billion, or 100 % of its net income.

Compared to the prior quarter, common shareholders» net income from Continuing Operations, diluted earnings per common share and adjusted cash earnings per common share were each down 38 % primarily due to the impact of higher provisions for credit losses.

BOSTON (March 12, 2018)-- MFS Investment Grade Municipal Trust (the «fund»)(NYSE: CXH) announced today that it will conduct a cash tender offer to purchase up to 7.5 percent of the fund's outstanding common shares (the «shares») at a price per share equal to 98 percent of the fund's net asset value (NAV) per share as of the close of regular trading on the New York Stock Exchange (NYSE) on the date the tender offer expires.

Adjusting for the more than $ 130 per share of net cash, GOOG trades at a below - market multiple of earnings despite its competitively protected business, which we believe can grow at above market rates for many years.

Icahn said Apple should be trading at 20 times earnings per share, which taken together with net cash of $ 22 per share works out to $ 216 per share.

The acquisition is expected to be accretive in the first year to Concho's key per - share metrics, including net asset value, earnings, cash flow and debt - adjusted growth.

Accenture sells for less than 15x EPS, net of more than $ 7 per share of cash on the balance sheet.

In order to uncover which PE multiple is most appropriate to place on a firm's earnings stream (its net diluted earnings per share), we must use a discounted cash flow process.

The net balance sheet position is captured in a discounted cash - flow process, but it is not readily apparent in any PE multiple assessment that only considers a firm's stock price and its earnings per share.

Thanks to STORE's skilled use of long - term fixed rate debt, the net cash spread (cash yield minus cost of capital) generally stays the same, allowing for profitable growth of AFFO per share and thus the dividend.

Net Debit is your total cash outlay (per share) to enter one of these trades.

The company performance elements reward companies with consistently positive cash flow from operations and year - over-year increases in revenue, net income and earnings per share.

The convertible security issued by MNOV would allow each AVGN stockholder at their election to either (i) convert each share of the convertible security into MNOV at a conversion price of $ 4.00 per share or (ii) have the convertible security redeemed for cash in an amount per share that represents the Net Cash Assets per share of Acash in an amount per share that represents the Net Cash Assets per share of ACash Assets per share of AVGN.

We esimate AVGN's net cash value at $ 43.5 M or $ 1.46 per share.

MathStar Inc's (OTC: MATH) board has rejected the $ 1.04 per share cash merger offer from PureChoice, Inc. because «the $ 1.04 per share price is less than the liquidation value of MathStar, including the value from any technology sale, and, in the Merger, MathStar's shareholders would derive no value from MathStar's net operating loss carryforwards.»

The convertible security issued by MediciNova as consideration would allow each Avigen stockholder at their election to either (i) convert each share of such convertible security into shares of MediciNova common stock at a conversion price of $ 4.00 per share at certain pre-specified accelerated conversion dates or the Final Conversion Date or (ii) have the convertible security redeemed by MediciNova on the Final Conversion Date for cash in an amount per share which represents the Net Cash Assets per share of Avicash in an amount per share which represents the Net Cash Assets per share of AviCash Assets per share of Avigen.

At its $ 1.04 closing price yesterday, AVGN is trading at a 20 % discount to our estimate of its net cash value of $ 37M or $ 1.24 per share.

With all the money staying with the thrift, its new net worth is $ 15 per share (cash of $ 100 million plus the pre-existing net worth of $ 50 million divided by the 10 million shares).

In our initial post, we noted that AVGN's net cash position was $ 36.5 M. Assuming that the $ 7M sale was for cash, adding it to AVGN's cash position gives it a net cash value we estimate at $ 43.5 M or $ 1.46 per share, 122 % higher than its Friday close.

The price of the unit of cash was $ 1 (e.g. one share of a typical money - market fund) and the price per share of the fund was equal to the actual net asset value (NAV) of the fund on the transaction date.

Its liquidating value is predominantly cash, so much so that MEMS has net cash of around $ 62M or $ 2.60 per share, which is around 60 % higher than its stock price.

Our estimate of MATH's liquidation value is its net cash value after deducting around $ 2M of cash burn, professional fees and other liquidation costs, or around $ 11.7 M or $ 1.27 per share.

We estimate MATH's net cash value to be around $ 11.7 M or $ 1.27 per share.

With $ 32.2 M or $ 0.71 per share in cash and equivalents on the balance sheet and total liabilities of $ 12.7 M or $ 0.28 per share, ABTL is trading at its net cash value of $ 0.43.

To put this price in perspective, A&P had net current assets $ 38 per share, including $ 24 of cash.

* The Board believes it can deliver more than $ 1.20 per share from net cash assets less wind down costs, rights to approximately $ 6 million ($ 0.20 per share) of near - term Genzyme payments and the sale of AV411.

While BVF's slate was not successful at the special meeting, AVGN's board now plans to develop its own plan of liquidation, which should put a floor on AVGN's stock at around its net cash value of $ 37M or $ 1.24 per share less wind down costs.

* The Board believes that the offer price of $ 1.20 per share is approximately the company's current net cash value less wind down costs, but does not reflect the value for the company's other assets, including its AV411 pain and addiction program and rights to future payments from Genzyme Corporation.

The net cash estimate does not take into account AVGN's AV411 assets and program or near term payments from Genzyme, which could be worth as much as $ 6M to $ 25M or between $ 0.18 or $ 0.75 per share more (Thanks Double F).

Around the same time the CIT deal was playing out, Klarman took a sizable stake in Facet Biotech — a small biotech company spun off in December 2008 from PDL BioPharma — for an average cost of $ 9 even though it had $ 17 per share in net cash at the time of the spinoff.

IKAN's liquidating value is predominantly cash, and it has a net cash value of $ 41.2 M or $ 1.43 per share.

We estimated the liquidation value to be anywhere from nil to $ 259M or ~ $ 10.85 per share and the net cash value from nil to $ 228M or $ 10.54 per share, so it wasn't a typical liquidation play for us.

IKAN's net cash value is $ 41.2 M or $ 1.43 per share.

$ 10.5 M off the cash reduces SOAP's net cash value to around $ 76M or $ 4.95 per share.

The current 11.625 p share price is a 44 % discount to 20.7 p of net cash / investments per share, and a massive 63 % discount to my latest 31.1 p estimate of intrinsic value per share.

The company's net cash value is around $ 15.6 M or $ 0.82 per share.